Effect of steroid injection on carpal tunnel syndrome with bifid median nerve
USG-guided Steroid Injection Treatment: Efficacy of in Patients With Bifid Median Nerve Diagnosed Carpal Tunnel Syndrome Versus With Non-bifid Median Nerve Diagnosed Carpal Tunnel Syndrome:A Single-blind Randomized Controlled Study
This study is testing if steroid injections can help relieve symptoms for people with carpal tunnel syndrome who have a bifid median nerve.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Ankara Etlik City Hospital Government |
| Locations | 1 site (Ankara, Ankara) |
| Trial ID | NCT06599086 on ClinicalTrials.gov |
What this trial studies
This study investigates the efficacy of corticosteroid injections in patients diagnosed with carpal tunnel syndrome (CTS) who have a bifid median nerve. It is a prospective, double-blind randomized controlled trial involving patients aged 18-65 with moderate CTS confirmed by electrophysiological tests. The study will assess pain levels, symptom severity, and functional status before and after treatment using various evaluation methods, including ultrasound to measure median nerve characteristics. A total of 40 patients will be included in each treatment group to ensure statistical significance.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-65 with clinically diagnosed moderate carpal tunnel syndrome and confirmed bifid median nerve.
Not a fit: Patients with a history of certain neurological disorders, previous wrist surgery, or other median nerve variations may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could provide significant relief from symptoms of carpal tunnel syndrome for patients with a bifid median nerve.
How similar studies have performed: While there is limited research specifically on bifid median nerves, corticosteroid injections have shown efficacy in treating carpal tunnel syndrome in other studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being between the ages of 18-65 * Being clinically diagnosed with Carpal Tunnel Syndrome * Confirmation of mild and moderate Carpal Tunnel Syndrome diagnosis with EMG * Diagnosis of bifid median nerve after ultrasound evaluation, No variation was detected for the control group either. * Having typical Carpal Tunnel Syndrome symptoms for at least 3 months Exclusion Criteria: * History of polyneuropathy, brachial plexopathy, thoracic outlet syndrome, or wrist surgery * History of Inflammatory arthritis, hypothyroidism, pregnancy,rheumatological disorders or heart battery * current warfarin use, Prior steroid injection for CTS, trauma or neoplasm at the injection site, hypersensitivity to corticosteroids or skin infection at the injection site * other median nerve variations and presence of persistent median artery.
Where this trial is running
Ankara, Ankara
- Etlik City Hospital — Ankara, Ankara, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Yunus Burak Bayir, Speci̇ali̇st
- Email: yunusburakbayir@gmail.com
- Phone: 05058083317
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.